Author: Dorian Fitzwilliam

5Apr

Understanding the FDA Black Box Warning for Adolescent Antidepressants

Posted by Dorian Fitzwilliam 3 Comments

Learn about the FDA Black Box warning for adolescent antidepressants, the actual risks of suicidality, and how to safely monitor teens during treatment.

30Mar

Digoxin Interactions: What Heart Patients Need to Monitor

Posted by Dorian Fitzwilliam 12 Comments

A guide for heart patients on Digoxin safety, covering drug interactions, food risks, and essential monitoring protocols to prevent toxicity.

29Mar

Drug interaction issues: when generics interact unexpectedly explained

Posted by Dorian Fitzwilliam 8 Comments

Understand the realities of generic drug interactions. Learn which medications need caution, why generics sometimes cause side effects, and how to monitor your safety effectively.

27Mar

Alpha-1 Antitrypsin Deficiency: Understanding Genetic COPD and Modern Treatments

Posted by Dorian Fitzwilliam 9 Comments

Understanding Alpha-1 Antitrypsin Deficiency as a genetic cause of COPD, covering symptoms, diagnostic delays, and modern augmentation therapy options.

22Mar

How to Coordinate Multiple Prescriptions for Fewer Copays

Posted by Dorian Fitzwilliam 10 Comments

Learn how medication synchronization helps patients with multiple prescriptions reduce copays, avoid missed doses, and cut pharmacy visits from 12 to 4 per year. A proven, free service offered by major U.S. pharmacies.

21Mar

How to Handle Expired Controlled Substances and Narcotics: DEA-Compliant Disposal Steps

Posted by Dorian Fitzwilliam 14 Comments

Learn the legal, step-by-step process for disposing of expired controlled substances and narcotics according to DEA regulations. Avoid fines, prevent diversion, and protect public safety with compliant disposal methods.

20Mar

FDA Authorization of Generics: Legal Basis and Approval Process

Posted by Dorian Fitzwilliam 8 Comments

The FDA approves generic drugs through a science-based process rooted in the 1984 Hatch-Waxman Act. Generics must match brand drugs in active ingredients, strength, and bioequivalence, ensuring safety and affordability. Over 90% of U.S. prescriptions are for generics, saving billions annually.

20Mar

FDA Authorization of Generics: Legal Basis and Approval Process

Posted by Dorian Fitzwilliam 15 Comments

The FDA approves generic drugs through the Hatch-Waxman Act and ANDA pathway, ensuring they match brand-name drugs in safety, strength, and effectiveness. Over 90% of U.S. prescriptions are filled with generics, saving billions annually.

14Mar

Accidental Pediatric Medication Overdose: How to Prevent It and What to Do If It Happens

Posted by Dorian Fitzwilliam 15 Comments

Accidental pediatric medication overdoses are common but preventable. Learn how child-resistant packaging, dosing errors, and unsafe storage put kids at risk-and what real steps parents can take to protect them.

8Mar

MAOI Dietary Restrictions: Tyramine Triggers and Safety Plan

Posted by Dorian Fitzwilliam 13 Comments

MAOI antidepressants require strict dietary restrictions to avoid tyramine-triggered hypertensive crises. Learn which foods are truly risky, how modern food science changes old rules, and how to build a personalized safety plan.